Issued to Mayo clinic for performance outcomes 1 and 2 from July 21 announcement? I assume these are: pilot trial completion and acceptance of proof of concept (1,186,153 shares); and FDA clearance of herabeat plus for home care (1,581,538 shares).
hopefully Mayo outcome 3, commercial launch, isn't to far away.
Ann: Appendix 2A, page-2
Add HMD (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
2.4¢ |
Change
0.000(0.00%) |
Mkt cap ! $15.19M | |||
| Open | High | Low | Value | Volume |
| 2.4¢ | 2.4¢ | 2.4¢ | $3.976K | 165.6K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 2007082 | 2.3¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 2.4¢ | 263773 | 3 |
View Market Depth
| Last trade - 14.42pm 09/07/2024 (20 minute delay) ? |
| HMD (ASX) Chart |